Industry & Business

Diaceutics to Use Artificial Intelligence to Improve Diagnosis and Treatment of Patients

 Breaking News
  • EIB to Back €1.2 Billion Pan-European Renewable Investment Through Irish NTR Fund The world’s largest international financier for renewable energy, the European Investment Bank, will back renewable energy investment across Europe in co-operation with Dublin-based NTR plc. The EIB’s €84 million backing for the NTR Renewable Energy Income Fund II was announced at an EIB investment conference at the Central Bank of Ireland attended by more than [...]...
  • ABP’s Olleco on Shortlist For Davos Sustainability Award ABP Food Group’s renewable division, Olleco, has been shortlisted for a prestigious ‘Circular’ sustainability award for its development of a circular economy model with McDonald’s and Arla Foods in the UK. The awards are an initiative of the World Economic Forum and the Forum of Young Global Leaders and winners will be announced at the [...]...
  • Pioneering Proteomics Researcher and Entrepreneur Receives the NovaUCD 2018 Innovation Award The NovaUCD 2018 Innovation Award has been presented to University College Dublin’s (UCD) Professor Stephen Pennington (pictured), a global leader in proteomics (the study of proteins) research and innovation. The Award was presented to him in recognition of his commitment and success in protein biomarker research, undertaken during the last 15-years at the UCD School [...]...
  • National Manufacturing & Supply Chain Conference & Exhibition 2019 – Thursday, January 17th – Citywest Hotel, Dublin Approximately 3,000 people from all over Ireland are expected to visit the 2019 National Manufacturing & Supply Chain Conference & Exhibition at the Citywest Hotel, Dublin on Thursday, January 17th, making the event the largest gathering of the manufacturing and supply chain community in the country. Now in its sixth year, the National Manufacturing and Supply [...]...
  • DIT Launches New MSc in Transport and Mobility Over 250 million journeys were taken by passengers on Irish public transport services in 2017, and with the population set to increase, this number is likely to continue growing in the coming years. Dublin Institute of Technology (DIT) has launched Ireland’s first ever MSc programme in Transport and Mobility designed to equip graduates with the knowledge [...]...

Diaceutics to Use Artificial Intelligence to Improve Diagnosis and Treatment of Patients

Diaceutics to Use Artificial Intelligence to Improve Diagnosis and Treatment of Patients
March 07
09:26 2018

Diaceutics, the Irish company helping patients to receive potentially lifesaving medicine through better diagnostic testing, has announced a collaboration with computer hardware manufacturer Lenovo, and chip manufacturer Intel. The collaboration will enable Diaceutics to leverage their vast proprietary database of patient testing data in a revolutionary way.

Using artificial intelligence (AI) to see whether patients can be grouped according to diagnostic test information, the company is hopeful that this data can help identify ways to improve diagnosis, treatment and outcomes for patients with similar characteristics.

Utilising one of the most powerful workstations on the planet, with the Lenovo ThinkStation P920 powered by Intel Xeon Scalable processors, and a vast amount of complex testing data from hundreds of clinical laboratories, Diaceutics is aiming to get the right medicine to the right individuals at the right time by classifying patient groups and disease patterns.

After a number of biomarkers covering a variety of tumours and cancer types have been inputted, the machine learning system will be able to identify similarities and patterns within the testing data and highlight what is happening among groups of patients. Essentially, the organisation of this information could mean that at-risk patients can be identified, diagnosed and treated much faster.

Considering that an estimated 78,000 cancer patients are not properly tested each year in the United States and therefore are being denied access to potentially lifesaving medication, this collaboration could further transform the area of personalised medicine. Diaceutics has given more than half a million patients the best possible chance of getting to better treatment through better testing.  The findings from the collaboration will be presented at a series of upcoming conferences.

Peter Keeling (pictured), chief executive officer of Diaceutics, said: “Artificial intelligence can make a very strong and positive impact on precision medicine and we are excited to be moving the boundaries with this highly innovative technology. We can now look at data in a novel way. No longer will we only be  making decisions based on diagnostic data. Artificial intelligence allows us to look at the complete patient journey from initial testing and diagnosis, and on to the ultimate treatment. The result will be significantly better patient testing and likely improved patient outcomes, such as longer cancer survivorship rates.

“This collaboration is a major step in our mission to help patients, by helping them find the right precision medicine at the right time. We are using artificial intelligence to enable the world to unlock the true life changing promise of precision medicine.”

About Author

admin

admin

Related Articles

New Subscriber





Subscribe Here



Advertisements



















National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories



Upcoming Events

  • No upcoming events
AEC v1.0.4